Abstract
The commonly accepted hypothesis explaining the mechanism of action of pyrazinamide (PZA) is based on the assumption that PZA-susceptible Mycobacterium tuberculosis strains produce pyrazinamidase, which hydrolyzes PZA to the antibacterial moiety pyrazinoic acid (POA). It is not clear whether POA has specific antimicrobial activity or the inhibition of growth caused by POA is due to its ability to lower the pH of the environment below the limits of tolerance of M. tuberculosis growth. We confirmed in this study that POA, depending on the concentration, lowered the pH of 7H12 broth (pH 6.0), which ranged from 5.8 at 120.0 micrograms/ml to 4.6 at 960.0 micrograms/ml. Therefore, we tested the inhibitory effects of different concentrations of POA in broth in which the final pH was adjusted to 5.6 by adding appropriate amounts of phosphoric acid or dipotassium phosphate. Under these conditions, we found a clear dose-response correlation, proving that POA does have specific antimicrobial activity. The MIC of POA at pH 5.6 was 240 to 480 micrograms/ml, 8- to 16-fold higher than the MIC of PZA under the same conditions and much higher than the concentrations achievable in humans. This suggests that the action of POA in an acid environment is a combined effect of its specific activity and its ability to lower the pH below the limits of tolerance of the target organism.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BONICKE R., LISBOA B. P. Typendifferenzierung der Tuberkulosebakterien mit Hilfe des Nicotinamidase-Tests. Tuberkulosearzt. 1959 Jun;13(6):377–384. [PubMed] [Google Scholar]
- Dickinson J. M., Mitchison D. A. Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis. Tubercle. 1970 Dec;51(4):389–396. doi: 10.1016/0041-3879(70)90004-8. [DOI] [PubMed] [Google Scholar]
- Ellard G. A. Absorption, metabolism and excretion of pyrazinamide in man. Tubercle. 1969 Jun;50(2):144–158. doi: 10.1016/0041-3879(69)90020-8. [DOI] [PubMed] [Google Scholar]
- Heifets L. B., Iseman M. D. Radiometric method for testing susceptibility of mycobacteria to pyrazinamide in 7H12 broth. J Clin Microbiol. 1985 Feb;21(2):200–204. doi: 10.1128/jcm.21.2.200-204.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Konno K., Feldmann F. M., McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967 Mar;95(3):461–469. doi: 10.1164/arrd.1967.95.3.461. [DOI] [PubMed] [Google Scholar]
- McDERMOTT W., TOMPSETT R. Activation of pyrazinamide and nicotinamide in acidic environments in vitro. Am Rev Tuberc. 1954 Oct;70(4):748–754. doi: 10.1164/art.1954.70.4.748. [DOI] [PubMed] [Google Scholar]
- Pavlov E. P., Tushov E. G., Koniaev G. A. Vliianie pirazinamida na pH uchastkov tsitoplazmy, okruzhaiushchikh fagotsitirovannye Mikobakterii. Probl Tuberk. 1974;(1):77–79. [PubMed] [Google Scholar]
- Salfinger M., Heifets L. B. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob Agents Chemother. 1988 Jul;32(7):1002–1004. doi: 10.1128/aac.32.7.1002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Snider D. E., Jr, Rogowski J., Zierski M., Bek E., Long M. W. Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland. Am Rev Respir Dis. 1982 Feb;125(2):265–267. doi: 10.1164/arrd.1982.125.2.265. [DOI] [PubMed] [Google Scholar]